Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer

Colloids and Surfaces B: Biointerfaces

Volumn 143, Issue , 2016, Pages 224-232

  Azhdarzadeh, Morteza ^a   Atyabi, Fatemeh ^a   Saei, Amir Ata ^b   Varnamkhasti, Behrang Shiri ^a   Omidi, Yadollah ^c   Fateh, Mohsen ^d   Ghavami, Mahdi ^e   Shanehsazzadeh, Saeed ^f   Dinarvand, Rassoul ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KAROLINSKA INSTITUTE   (Sweden)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d AVICENNA RESEARCH INSTITUTE   (Iran)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f NUCLEAR SCIENCE AND TECHNOLOGY RESEARCH INSTITUTE   (Iran)

Author keywords

MRI; MUC1 aptamer; Nanoparticles; Protein corona; SPION; Theranostics

Indexed keywords

CELLS; CYTOLOGY; CYTOTOXICITY; DISEASES; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; INFRARED DEVICES; IRON OXIDES; LIGHT SCATTERING; MAGNETIC RESONANCE IMAGING; METAL NANOPARTICLES; MICROEMULSIONS; NANOMAGNETICS; NANOPARTICLES; PROTEINS; TRANSMISSION ELECTRON MICROSCOPY; X RAY PHOTOELECTRON SPECTROSCOPY;

APTAMERS; IRON OXIDE NANOPARTICLE; MICRO-EMULSION METHODS; PHYSIO-CHEMICAL PROPERTIES; PROTEIN CORONAS; SPION; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; THERANOSTICS;

GOLD COATINGS;

APTAMER; GOLD NANOPARTICLE; MUCIN 1; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; BIOCOMPATIBLE COATED MATERIAL; GOLD; MAGNETITE NANOPARTICLE;

ANIMAL CELL; ARTICLE; BIOENGINEERING; CANCER CELL; CELL DEATH; CHEMICAL MODIFICATION; COLON CANCER; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOTOXICITY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; IN VITRO STUDY; LIGHT SCATTERING; MATERIAL COATING; MICROEMULSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHOTOTHERAPY; PHOTOTHERMAL THERAPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET RADIATION; X RAY PHOTOELECTRON SPECTROSCOPY; ANIMAL; CELL LINE; CELL SURVIVAL; CHEMISTRY; CHO CELL LINE; COLONIC NEOPLASMS; CRICETULUS; DRUG EFFECTS; HAMSTER; HT-29 CELL LINE; METABOLISM; MOUSE; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; THERANOSTIC NANOMEDICINE; ULTRASTRUCTURE;

ANIMALS; APTAMERS, NUCLEOTIDE; CELL LINE; CELL SURVIVAL; CHO CELLS; COATED MATERIALS, BIOCOMPATIBLE; COLONIC NEOPLASMS; CRICETINAE; CRICETULUS; GOLD; HT29 CELLS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; MUCIN-1; PHOTOCHEMOTHERAPY; PHOTOELECTRON SPECTROSCOPY; THERANOSTIC NANOMEDICINE;

EID: 84961680222     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2016.02.058     Document Type: Article

References (46)

1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics 2015, CA. Cancer J. Clin. 2015, 65:5-29.
2. Laurent S., Saei A.A., Behzadi S., Panahifar A., Mahmoudi M. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges. Expert Opin. Drug Deliv. 2014, 11:1449-1470.
3. Sharifi S., Seyednejad H., Laurent S., Atyabi F., Saei A.A., Mahmoudi M. Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging. Contrast Media Mol. Imaging 2015, 10:329-355.
4. Kuus-Reichel K., Grauer L., Karavodin L., Knott C., Krusemeier M., Kay N. Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?. Clin. Diagn. Lab. Immunol. 1994, 1:365-372.
5. Chester K.A., Hawkins R.E. Clinical issues in antibody design. Trends Biotechnol. 1995, 13:294-300.
6. Tiefenauer L.X., Kuehne G., Andres R.Y. Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging. Bioconjugate Chem. 1993, 4:347-352.
7. Brannon-Peppas L., Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 2012, 64:206-212.
8. Vigor K.L., Kyrtatos P.G., Minogue S., Al-Jamal K.T., Kogelberg H., Tolner B., Kostarelos K., Begent R.H., Pankhurst Q.A., Lythgoe M.F. Nanoparticles functionalised with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells. Biomaterials 2010, 31:1307-1315.
9. Sudimack J., Lee R.J. Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev. 2000, 41:147-162.
10. Zhao Z., Xu L., Shi X., Tan W., Fang X., Shangguan D. Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells. Analyst 2009, 134:1808-1814.
11. Huang Y.-F., Chang H.-T., Tan W. Cancer cell targeting using multiple aptamers conjugated on nanorods. Anal. Chem. 2008, 80:567-572.
12. Chen M., Yamamuro S., Farrell D., Majetich S.A. Gold-coated iron nanoparticles for biomedical applications. J. Appl. Phys. 2003, 93:7551-7553.
13. Huang X., El-Sayed I.H., Qian W., El-Sayed M.A. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc. 2006, 128:2115-2120.
14. Song Y., Xu X., MacRenaris K.W., Zhang X.Q., Mirkin C.A., Meade T.J. Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging. Angew. Chem. Int. Ed. 2009, 48:9143-9147.
15. Panahifar A., Mahmoudi M., Doschak M.R. Synthesis and in vitro evaluation of bone-seeking superparamagnetic iron oxide nanoparticles as contrast agents for imaging bone metabolic activity. ACS Appl. Mater. Interfaces 2013, 5:5219-5226.
16. Lyon J.L., Fleming D.A., Stone M.B., Schiffer P., Williams M.E. Synthesis of Fe oxide core/Au shell nanoparticles by iterative hydroxylamine seeding. Nano Lett. 2004, 4:719-723.
17. Azhdarzadeh M., Saei A.A., Sharifi S., Hajipour M.J., Alkilany A.M., Sharifzadeh M., Ramazani F., Laurent S., Mashaghi A., Mahmoudi M. Nanotoxicology: advances and pitfalls in research methodology. Nanomedicine 2015, 10:2931-2952.
18. Monopoli M.P., Walczyk D., Campbell A., Elia G., Lynch I., Baldelli Bombelli F., Dawson K.A. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Amer. Chem. Soc. 2011, 133:2525-2534.
19. Mahmoudi M., Abdelmonem A.M., Behzadi S., Clement J.H., Dutz S., Ejtehadi M.R., Hartmann R., Kantner K., Linne U., Maffre P. Temperature: the ignored factor at the nanobio interface. ACS Nano 2013, 7:6555-6562.
20. Kooi M.E., Cappendijk V., Cleutjens K., Kessels A., Kitslaar P., Borgers M., Frederik P., Daemen M., Van Engelshoven J. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003, 107:2453-2458.
21. Bulte J.W., Douglas T., Witwer B., Zhang S.-C., Strable E., Lewis B.K., Zywicke H., Miller B., van Gelderen P., Moskowitz B.M. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 2001, 19:1141-1147.
22. Jordan A., Scholz R., Wust P., Fähling H., Felix R. Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J. Magn. Magn. Mater. 1999, 201:413-419.
23. Yang C., Rait A., Pirollo K.F., Dagata J.A., Farkas N., Chang E.H. Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo, Nanomedicine: nanotechnology. Biol. Med. 2008, 4:318-329.
24. Saei A.A., Barzegari A., Majd M.H., Asgari D., Omidi Y. Fe3O4 nanoparticles engineered for plasmid DNA delivery to Escherichia coli. J. Nanopart. Res. 2014, 16:1-11.
25. Durgadas C., Sharma C.P., Sreenivasan K. Fluorescent and superparamagnetic hybrid quantum clusters for magnetic separation and imaging of cancer cells from blood. Nanoscale 2011, 3:4780-4787.
26. Thorek D.L., Chen A.K., Czupryna J., Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann. Biomed. Eng. 2006, 34:23-38.
27. Zhang C., Wängler B., Morgenstern B., Zentgraf H., Eisenhut M., Untenecker H., Krüger R., Huss R., Seliger C., Semmler W. Silica-and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging. Langmuir 2007, 23:1427-1434.
28. Nath S., Kaittanis C., Ramachandran V., Dalal N.S., Perez J.M. Synthesis, magnetic characterization, and sensing applications of novel dextran-coated iron oxide nanorods. Chem. Mater. 2009, 21:1761-1767.
29. Arami H., Stephen Z., Veiseh O., Zhang M. Chitosan-coated Iron Oxide Nanoparticles for Molecular Imaging and Drug Delivery, Chitosan for Biomaterials I 2011, 163-184. Springer.
30. Liu D., Wu W., Ling J., Wen S., Gu N., Zhang X. Effective PEGylation of iron oxide nanoparticles for high performance in vivo cancer imaging. Adv. Funct. Mater. 2011, 21:1498-1504.
31. Hajdú A., Szekeres M., Tóth I.Y., Bauer R.A., Mihály J., Zupkó I., Tombácz E. Enhanced stability of polyacrylate-coated magnetite nanoparticles in biorelevant media. Colloids Surf. B. Biointerfaces 2012, 94:242-249.
32. Shubayev V.I., Pisanic T.R., Jin S. Magnetic nanoparticles for theragnostics. Adv. Drug Deliv. Rev. 2009, 61:467-477.
33. Sun C., Lee J.S., Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv. Drug Deliv. Rev. 2008, 60:1252-1265.
34. Saie A.A., Ray M., Mahmoudi M., Rotello V.M. Engineering the nanoparticle-Protein interface for cancer therapeutics, nanotechnology-Based precision tools for the detection and treatment of cancer 2015, 245-273. Springer.
35. Walczyk D., Bombelli F.B., Monopoli M.P., Lynch I., Dawson K.A. What the cell sees in bionanoscience. J. Am. Chem. Soc. 2010, 132:5761-5768.
36. Hu Z., Zhang H., Zhang Y., Wu R.a., Zou H. Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles. Colloids Surf. B. Biointerfaces 2014, 121:354-361.
37. Hu W., Peng C., Lv M., Li X., Zhang Y., Chen N., Fan C., Huang Q. Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano 2011, 5:3693-3700.
38. Lesniak A., Fenaroli F., Monopoli M.P., Åberg C., Dawson K.A., Salvati A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 2012, 6:5845-5857.
39. Lynch I., Salvati A., Dawson K.A. Protein-nanoparticle interactions: what does the cell see?. Nat. Nanotechnol. 2009, 4:546-547.
40. Liong M., Lu J., Kovochich M., Xia T., Ruehm S.G., Nel A.E., Tamanoi F., Zink J.I. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS nano 2008, 2:889-896.
41. Blackburn M., Wheldon T., Field S., Goldman J. The sensitivity to hyperthermia of human granulocyte/macrophage progenitor cells (CFU-GM) derived from blood or marrow of normal subjects and patients with chronic granulocytic leukaemia. Br. J. Cancer 1984, 50:745.
42. Lu A.H., Salabas E.e.L., Schüth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew. Chem. Int. Ed. 2007, 46:1222-1244.
43. Tong L., Zhao Y., Huff T.B., Hansen M.N., Wei A., Cheng J.X. Gold nanorods mediate tumor cell death by compromising membrane integrity. Adv. Mater. 2007, 19:3136-3141.
44. Raji V., Kumar J., Rejiya C., Vibin M., Shenoi V.N., Abraham A. Selective photothermal efficiency of citrate capped gold nanoparticles for destruction of cancer cells. Exp. Cell Res. 2011, 317:2052-2058.
45. Markovic Z.M., Harhaji-Trajkovic L.M., Todorovic-Markovic B.M., Kepić D.P., Arsikin K.M., Jovanović S.P., Pantovic A.C., Dramićanin M.D., Trajkovic V.S. In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes. Biomaterials 2011, 32:1121-1129.
46. Liu S.-Y., Liang Z.-S., Gao F., Luo S.-F., Lu G.-Q. In vitro photothermal study of gold nanoshells functionalized with small targeting peptides to liver cancer cells. J. Mater. Sci. 2010, 21:665-674.